Biogen Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 05:39

Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD